Kayentis & RWS partnering for successful eCOA study implementation

RWS and Kayentis (global provider of eCOA and DCT solutions) were selected to create and implement the electronic versions of the COAs (eCOAs) on a high priority Global Small Cell Lung Cancer Phase II Study for a pioneer in biotechnology. . The study required seven patient-facing COAs, translated into 26 languages, to be implemented into Kayentis’ Clin’form solution using ten-inch tablet devices for use in the global study with 100 participating sites. . The collaborative work on the study involved: .